Singapore markets open in 1 hour 14 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
1.1700-0.0300 (-2.50%)
At close: 10:57AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 28.13M
Enterprise value 72.21M
Trailing P/E 4.03
Forward P/E 6.49
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.22
Price/book (mrq)0.97
Enterprise value/revenue 0.62
Enterprise value/EBITDA 3.66

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 326.90%
S&P500 52-week change 324.78%
52-week high 32.5620
52-week low 30.8380
50-day moving average 31.2097
200-day moving average 31.5817

Share statistics

Avg vol (3-month) 314.26k
Avg vol (10-day) 310.15k
Shares outstanding 524.46M
Implied shares outstanding 624.56M
Float 822.13M
% held by insiders 18.69%
% held by institutions 18.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Dec 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 5.08%
Operating margin (ttm)6.22%

Management effectiveness

Return on assets (ttm)5.21%
Return on equity (ttm)26.14%

Income statement

Revenue (ttm)115.72M
Revenue per share (ttm)5.46
Quarterly revenue growth (yoy)-12.30%
Gross profit (ttm)N/A
EBITDA 18.32M
Net income avi to common (ttm)5.88M
Diluted EPS (ttm)0.2900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.21M
Total cash per share (mrq)0.34
Total debt (mrq)52.29M
Total debt/equity (mrq)176.88%
Current ratio (mrq)1.11
Book value per share (mrq)1.21

Cash flow statement

Operating cash flow (ttm)20.97M
Levered free cash flow (ttm)8.24M